ARTICLE | Clinical News

Cetirizine regulatory update

June 27, 2016 7:00 AM UTC

FDA accepted and granted Priority Review to an NDA from Nicox for AC-170 to treat ocular itching associated with allergic conjunctivitis. The PDUFA date is Oct. 18. The product is a topical formulation of cetirizine, a histamine H1 receptor (HRH1) antagonist. ...